BioSpace News Archive

Sharps Technology, Inc. announced the closing of its previously announced registered direct offering and concurrent private placement with institutional investors.

RaySearch Laboratories AB announces that Ion Beam Applications S.A., market leader in proton therapy, has placed an order for RayStation®* treatment planning system and the oncology information system RayCare®* for installation at CRO National Cancer Institute in Aviano, Italy.

Bausch + Lomb Corporation announced it has completed its acquisition of XIIDRA 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease focusing on inflammation associated with dry eye, and certain other ophthalmology assets.

Horizon Therapeutics plc (Nasdaq: HZNP) today announced new data showing that disrupting the recommended TEPEZZA treatment regimen by lengthening the amount of time between infusions can increase the need for a second course of treatment.

Bausch + Lomb Corporation (“Bausch + Lomb”) (NYSE/TSX:BLCO) today announced it has completed its acquisition of XIIDRA® (lifitegrast ophthalmic solution) 5%, a non-steroid eye drop specifically approved to treat the signs and symptoms of dry eye disease focusing on inflammation associated with dry eye, and certain other ophthalmology assets.

Estrella Immunopharma, Inc., formerly known as TradeUP Acquisition Corp., announced the successful closing of its business combination with Estrella Biopharma, Inc., a preclinical-stage biopharmaceutical company developing T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

Regel Therapeutics announced that based upon the groundbreaking work of its Co-Founder and Chief Scientific Officer Dr. Navneet Matharu, it has been selected to receive $1 Million in non-dilutive funding from the HS Chau Foundation through the Women in Enterprising Science Program at the Innovative Genomics Institute founded by CRISPR pioneer and Nobel laureate Dr. Jennifer Doudna.

ARUP Laboratories today announced the formation of the new ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ (R&I Institute).

September 28, 2023) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) is pleased to announce that the company recently entered into a third amendment to its February 2021

Bloom Burton & Co. (“Bloom Burton”) is pleased to announce Stephen Dilly, former Chief Executive Officer of Sierra Oncology, as the recipient of the 2023 Bloom Burton Award.